Aeolus Pharmaceuticals Inc (AOLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 09-2013 | 06-2013 | 03-2013 | 12-2012 | 09-2012 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 869 | 2,732 | 1,926 | 2 | 281 |
| Receivables | 370 | 343 | 1,620 | 1,550 | 781 |
| Other current assets | 657 | 935 | 1,005 | 0 | 101 |
| TOTAL | $1,935 | $4,061 | $4,643 | $1,606 | $1,224 |
| Non-Current Assets | |||||
| Investments And Advances | 32 | 32 | 32 | 32 | 32 |
| TOTAL | $32 | $32 | $32 | $32 | $32 |
| Total Assets | $1,966 | $4,093 | $4,675 | $1,638 | $1,256 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 579 | 2,026 | 2,023 | 3,064 | 2,167 |
| TOTAL | $1,261 | $2,998 | $3,069 | $3,064 | $2,272 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 682 | 972 | 1,046 | N/A | 105 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 14,809 | 19,319 |
| TOTAL | $N/A | $N/A | $N/A | $14,809 | $19,319 |
| Total Liabilities | $1,261 | $2,998 | $3,069 | $17,873 | $21,591 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 134,550 | 134,550 | 134,550 | 62,732 | 62,732 |
| Common Shares | 1,346 | 1,346 | 1,346 | 627 | 627 |
| Retained earnings | -183,922 | -183,255 | -182,469 | -176,686 | -180,714 |
| Other shareholders' equity | 5 | 5 | 5 | 5 | 5 |
| TOTAL | $705 | $1,095 | $1,606 | $-16,235 | $-20,335 |
| Total Liabilities And Equity | $1,966 | $4,093 | $4,675 | $1,638 | $1,256 |